Yorke Justin W. - 05 Aug 2021 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Justin W. Yorke by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
05 Aug 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
01 Sep 2021, 16:41:08 UTC
Date Of Original Report
09 Aug 2021
Next filing
31 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award +1,169 +14% 9,323 05 Aug 2021 Direct F1, F2
holding PCSA Common Stock 544,117 05 Aug 2021 By Arroyo Fund, LLC, San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.
F2 The previous filing overstated the number of securities directly owned by the reporting person and understated the number of securities indirectly owned by the reporting person.